This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Alexza Pharmaceuticals Inc (ALXA)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -39.62M -27.98M -40.53M -1.48M
Operating Gains/Losses -15.00K -415.00K 0.00 79.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -129.00K 10.00M -10.00M 1.41M
(Increase) Decrease in Inventories -3.45M 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 200.00K -147.00K 0.00
(Decrease) Increase In Payables 1.64M -1.46M 822.00K 76.00K
(Decrease) Increase In Other Current Liabilities 1.12M 559.00K -498.00K 3.92M
(Increase) Decrease In Other Working Capital -4.46M -6.83M 3.97M -1.17M
Other Non-Cash Items 40.48M 3.10M 6.41M 886.00K
Net Cash From Continuing Operations -612.00K -18.24M -34.43M 8.59M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -612.00K -18.24M -34.43M 8.59M
Sale of Property, Plant & Equipment 16.00K 425.00K 0.00 29.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 10.65M 2.00M 54.04M 41.94M
Purchases of Property, Plant & Equipment -1.78M -452.00K -496.00K -9.18M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -19.23M 0.00 -28.46M -63.43M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -10.34M 1.97M 25.08M -30.64M
Issuance of Debt 15.00M 0.00 0.00 14.81M
Cash Used for Financing Activities
Issuance of Capital Stock 6.58M 35.24M 16.14M 17.05M
Repayment of Long-Term Debt -5.77M -6.11M -5.56M -2.09M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -5.26M -10.05M 0.00 -7.50M
Net Cash From Financing Activities 10.55M 19.08M 10.58M 22.27M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -409.00K 2.81M 1.23M 221.00K

ALXA Alexza Pharmaceuticals Inc

Analysts Ratings for ALXA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ALXA Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs